Evidence map›Paper›PMID 38350616›Full record

ReviewJournal of the Royal Society, Interface2024

Accelerated simulation methodologies for computational vascular flow modelling.

Michael MacRaild, Ali Sarrami-Foroushani, Toni Lassila, Alejandro F Frangi

Abstract readReview
In one paragraph

Review in Journal of the Royal Society, Interface, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael MacRaildCentre for Computational Imaging and Simulation Technologies in Biomedicine (CISTIB), University of Leeds, Leeds, UK.ORCID 0009-0001-3307-743X
Ali Sarrami-ForoushaniCentre for Computational Imaging and Simulation Technologies in Biomedicine (CISTIB), University of Leeds, Leeds, UK.ORCID 0000-0001-8944-449X
Toni LassilaCentre for Computational Imaging and Simulation Technologies in Biomedicine (CISTIB), University of Leeds, Leeds, UK.ORCID 0000-0001-8947-1447
Alejandro F FrangiCentre for Computational Imaging and Simulation Technologies in Biomedicine (CISTIB), University of Leeds, Leeds, UK.ORCID 0000-0002-2675-528X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vascular flow modelling can improve our understanding of vascular pathologies and aid in developing safe and effective medical devices. Vascular flow models typically involve solving the nonlinear Navier-Stokes equations in complex anatomies and using physiological boundary conditions, often presenting a multi-physics and multi-scale computational problem to be solved. This leads to highly complex and expensive models that require excessive computational time. This review explores accelerated simulation methodologies, specifically focusing on computational vascular flow modelling. We review reduced order modelling (ROM) techniques like zero-/one-dimensional and modal decomposition-based ROMs and machine learning (ML) methods including ML-augmented ROMs, ML-based ROMs and physics-informed ML models. We discuss the applicability of each method to vascular flow acceleration and the effectiveness of the method in addressing domain-specific challenges. When available, we provide statistics on accuracy and speed-up factors for various applications related to vascular flow simulation acceleration. Our findings indicate that each type of model has strengths and limitations depending on the context. To accelerate real-world vascular flow problems, we propose future research on developing multi-scale acceleration methods capable of handling the significant geometric variability inherent to such problems.

Indexed as

HemodynamicsModels, CardiovascularAccelerationComputer Simulationhaemodynamicsmachine learningreduced order modellingsimulation accelerationvascular flow modelling

Identifiers

PMID38350616
PMCPMC10864099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.